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Introduction {#sec1}
============

The ability to generate human endothelial cells (ECs) from human induced pluripotent stem cells (hiPSCs) makes it possible to consider these cells for therapeutic applications, tissue engineering, and regeneration and for disease modeling ([@bib31], [@bib38], [@bib43], [@bib49]). In addition to appropriate marker expression, proper functionality is required to realize most applications. While multiple protocols have described hiPSC-EC differentiation ([@bib39], [@bib45], [@bib46], [@bib47], [@bib56], [@bib57], [@bib70]), these ECs have not yet been able to recapitulate all features of their adult (primary) counterparts ([@bib29], [@bib54], [@bib61], [@bib78]).

One key aspect of endothelial function is the ability to synthesize and maintain a glycocalyx surface layer ([@bib6], [@bib23], [@bib53], [@bib69]). In the endothelium this consists of the polysaccharides heparan sulfate, hyaluronan, and chondroitin sulfate, and the proteins that interact with them; together, they mediate most of the characteristic functional aspects of the endothelium ([@bib51], [@bib74]). For example, the heparan sulfate chains provide the specific binding motifs required for protein-receptor interaction and the formation of surface gradients of chemokines and growth factors ([@bib52]). The surface layer also functions as a barrier to control capillary fluid filtration and is critical for endothelial shear sensing and, hence, inducing endothelial quiescence ([@bib1], [@bib4], [@bib5], [@bib42], [@bib64]). Glycocalyx composition is regulated by the interplay of shear sensing with subsequent downstream glycolysis inhibition, which renders glycolytic intermediates available for glucobiosynthetic pathways, such as glycocalyx synthesis ([@bib10]).

To assess this aspect of functionality, we examined the ability of hiPSC-ECs to respond to shear stress exposure and to express a glycocalyx surface layer, and compared their ability to adopt a shear-sensitive endothelial phenotype with human microvascular ECs (hMVECs). Since several studies have demonstrated that mitochondria are linked to cell fate determination and development ([@bib12], [@bib24], [@bib27], [@bib32], [@bib40], [@bib50], [@bib67], [@bib72], [@bib79]), we investigated the effects of closing the mitochondrial permeability transition pore (mPTP) in hiPSC-ECs. While we observed no effect of shear stress as such, in contrast to hMVECs we found that mPTP closure induced mitochondrial maturation and decreased reactive oxygen species (ROS), which restored the expression of an endothelial surface layer and adaptation to shear. In this respect, hiPSC-ECs exhibited functional maturation comparable with that of hMVECs.

Results {#sec2}
=======

Differentiation of hiPSCs toward ECs {#sec2.1}
------------------------------------

hiPSC lines used were generated using episomal plasmids ([@bib44]) and RNA reprogramming ([@bib59], [@bib75]) as described previously. For hiPSC-EC differentiation, we used a defined protocol described previously ([@bib29], [@bib46]) ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). Results of RNA sequencing, all metabolic assays, and key experiments were obtained and reproduced in ECs from three different hiPSC lines (hiPSC-L72, hiPSC-L99, and hiPSC-NCRM1). All other results are from NCRM1 (also used as undifferentiated control). In all experiments, we compared hiPSC-ECs with primary hMVECs. For the aspects relevant to this study, we have not found significant differences between HUVECs (human umbilical vein endothelial cells) and hMVECs ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2H).

Effects of Environmental Cues on iPSC-EC Functionality {#sec2.2}
------------------------------------------------------

To assess the effects of shear stress, we exposed hiPSC-ECs to a 5-dyne/cm^2^ laminar shear stress for 4 days. Previous studies have shown that shear stress of less than 24 h provokes an inflammatory-like response and that prolonged shear stress is necessary for the assessment of response to flow, such as alignment ([@bib17], [@bib18], [@bib26]). Principal component analysis (PCA) of total RNA-sequencing data revealed that hiPSC-ECs cultured under static conditions formed a distinct population compared with hMVECs and that although flow induced a change in transcriptome, the cells were still different from the mature hMVECs ([Figure 1](#fig1){ref-type="fig"}A). Even prolonged flow had little effect on alignment of hiPSC-ECs ([Figures 1](#fig1){ref-type="fig"}B and 1C) but instead resulted in unstable focal adherence junctions between the cells ([Figure 1](#fig1){ref-type="fig"}D). Co-culturing hiPSC-ECs with human kidney-derived perivascular stromal cells for 4 days also failed to improve the alignment of hiPSC-ECs with laminar flow ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B).Figure 1hiPSC-Derived Endothelial Cells Do Not Show a Functional Response to Shear Stress Accompanied by an Insufficient Glycocalyx(A) PCA plot of expression of all genes acquired from RNA sequencing of hiPSC NCRM1, mature ECs (hMVECs), and hiPSC-ECs NCRM1/L72/L99 in static conditions and after exposure to flow.(B--D) Representative cross-sectional confocal images stained for VE-cadherin (red) and Hoechst (blue) after 4 days of laminar flow (5 dyne/cm^2^) culture of hMVECs and hiPSC-EC NCRM1 show the alignment of cells to flow (B). Quantification of cell alignment after 4 days of laminar flow culture of hMVECs and hiPSC-ECs (100 cells/group) (C). Quantification of adherence junction remodeling as the ratio of unstable focal adherence junction (FAJ) over total adherence junction length after 4 days of laminar flow culture of hMVECs and hiPSC-ECs (50 cells/group) (D).(E and F) Representative cross-sectional and side-view confocal images stained for components of the glycocalyx (E). Hyaluronan (Neurocan, red), lectin (LEA, green) and heparan sulfate (JM403, green) after 4 days of laminar flow (5 dyne/cm^2^) culture of hMVECs and hiPSC-EC NCRM1 (E). Quantification of luminal thickness of hyaluronan, lectin *Lycopersicon esculentum*, and heparan sulfates after 4 days of laminar flow of hMVECs and hiPSC-ECs (8--16 cells/group) (F).Values are presented as mean ± SEM of n = 3--6 independent experiments. Non-paired two-tailed Student\'s t test was performed; ^∗^p \< 0.05, ^∗∗^p \< 0.001, ^∗∗∗^p \< 0.0001.

hiPSC-ECs Lack a Functional Glycocalyx {#sec2.3}
--------------------------------------

As the endothelial glycocalyx serves a primary shear stress sensor ([@bib1], [@bib42], [@bib64]), we determined whether hiPSC-ECs had a functional glycocalyx. To this end, we quantified the luminal thickness of hyaluronan, lectin binding, and heparan sulfate ([Figures 1](#fig1){ref-type="fig"}E and 1F). Luminal glycocalyx expression was significantly lower in hiPSC-ECs compared with hMVECs with an overall ∼50% decrease in thickness of hyaluronan, lectin, and heparan sulfates ([Figures 1](#fig1){ref-type="fig"}E and 1F), indicating insufficient and dysfunctional surface coverage that can be important for binding of growth factors, mechanotransduction, and vascular stability. Pericyte co-culture did not increase the luminal glycocalyx thickness either ([Figures S3](#mmc1){ref-type="supplementary-material"}C and S3D).

hiPSC-ECs Have Reduced Mitochondrial Function {#sec2.4}
---------------------------------------------

Since endothelial function is intrinsically linked to its metabolism ([@bib3], [@bib21]), we investigated the expression of metabolic enzyme genes. PCA revealed separate clustering of undifferentiated hiPSCs, hiPSC-ECs, and hMVECs, indicating that hiPSC-ECs exhibited a different metabolic gene-expression profile with hMVECs ([Figure 2](#fig2){ref-type="fig"}A). Functional measurements of the extracellular acidification rate (ECAR), an indicator of lactate production, showed similar glucose-induced glycolysis and maximal glycolytic capacity in three different hiPSC-EC cell lines compared with hMVECs ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Furthermore, ATP production was similar ([Figure S4](#mmc1){ref-type="supplementary-material"}C), dismissing the lack of energy production. RNA sequencing, however, showed a clear downregulation of several enzymes related to the tricarboxylic acid cycle, including isocitrate dehydrogenase and aconitase 1 ([Figure 2](#fig2){ref-type="fig"}B). The oxygen consumption rate (OCR), an indicator of mitochondrial function, showed dysfunction in hiPSC-ECs from all three hiPSC lines ([Figure 2](#fig2){ref-type="fig"}C) ([@bib77]) demonstrated by significantly reduced maximum mitochondrial respiration and mitochondrial reserve capacity ([Figures 2](#fig2){ref-type="fig"}D and 2E). This reduced mitochondrial activity was further confirmed by reduced NAD(P)H-dependent reduction of the tetrazolium dye MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) ([Figure 2](#fig2){ref-type="fig"}F).Figure 2hiPSC-ECs Have Dysfunctional Mitochondria(A) PCA plot of expression of all metabolic genes acquired from RNA sequencing of hiPSC NCRM1, hiPSC-ECs NCRM1/L72/L99, and mature ECs (hMVECs).(B) Heatmap of RNA-sequencing results of metabolic genes involved in the mitochondrial metabolism. Scale bar represents *Z* scores: blue indicates lower gene expression and red a higher gene expression.(C--E) Using a Seahorse XF flux analyzer, the oxygen consumption rate (OCR), an indicator of metabolic function, revealed mitochondrial dysfunction in three different hiPSC-EC cell lines (C). Both maximal mitochondrial respiration (D) and mitochondrial reserve capacity (E) were decreased (n = 4).(F) Mitochondrial activity was also tested by MTT (n = 4).Values are presented as mean ± SEM of n = 3--5 independent experiments. One-way ANOVA was performed; ^∗^p \< 0.05, ^∗∗^p \< 0.001, ^∗∗∗^p \< 0.0001.

hiPSC-ECs Have Immature Mitochondria {#sec2.5}
------------------------------------

hiPSC-ECs have higher numbers of mitochondria and mitochondrial DNA compared with hMVECs ([Figures 3](#fig3){ref-type="fig"}A and 3B). However, both confocal microscopy and transmission electron microscopy (TEM) revealed a distinctly different morphology of hiPSC-EC mitochondria compared with hMVECs ([Figures 3](#fig3){ref-type="fig"}D, 3E, and [S5](#mmc1){ref-type="supplementary-material"}A). TEM of the hiPSC-ECs showed round mitochondria with paucity of cristae, characteristic of immaturity. This was associated with increased cell-associated ROS ([Figure 3](#fig3){ref-type="fig"}C).Figure 3hiPSC-ECs Have an Increased Amount of Immature Mitochondria(A) Mitochondrial DNA measured by qPCR.(B) Mitochondrial density quantified on transmission electron microscopy (TEM) stitches (21 cells/group).(C) Fold change of fluorescent intensity/mg protein of ROS dye.(D) Representative cross-sectional confocal images stained for MitoTracker red (oxidative mitochondria) and MitoTracker green (mitochondria).(E) TEM images show the ultrastructure of mitochondria of hMVECs and hiPSC-EC NCRM1.Values are presented as mean ± SEM of n = 3 independent experiments. Non-paired two-tailed Student\'s t test was performed; ^∗^p \< 0.05, ^∗∗^p \< 0.001, ^∗∗∗^p \< 0.0001.

Mitochondrial Maturation by Permeability Transition Pore Closure {#sec2.6}
----------------------------------------------------------------

The high number of immature mitochondria and increased intracellular ROS in hiPSC-ECs suggested that the mitochondrial membrane permeability transition pore (mPTP) in hiPSC-ECs might be constitutively open ([@bib30], [@bib32]). During differentiation of hiPSC to hiPSC-ECs, this mPTP transporter should close in order to allow maturation of the mitochondria ([@bib32]). Cyclosporine A (CsA), an immunosuppressant, binds to mitochondrial cyclophilin D (CYPD) to block the calcium ion-induced permeability transition pore mPTP ([Figure 4](#fig4){ref-type="fig"}A), and treatment with CsA has been shown to induce mitochondrial maturation in myocytes ([@bib7], [@bib15], [@bib30], [@bib32]). To determine whether the mPTP was open in hiPSC-ECs, we used the cobalt/calcein quenching method ([@bib48]). In untreated hiPSC-ECs, calcein fluorescence leaked from the mitochondria due to an open mPTP, and calcein AM fluorescence was observed throughout the cell. However, when hiPSC-ECs were treated with 1.5 mM CsA for 30 min, only mitochondrial calcein fluorescence was observed, indicating that CsA closed the mPTP, preventing calcein leakage from the mitochondria. In untreated hMVECs, calcein fluorescence was only observed in the mitochondria, confirming the closed mPTP in mature ECs ([Figures 4](#fig4){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}B).Figure 4Treatment with Cyclosporine A Results in Closure of the mPTP and Subsequent Maturation of the Mitochondria(A) Schematic overview of mature and immature mitochondria. Cyclosporine A (CsA) binds to cyclophilin D (CYPD) and thereby closes the mitochondrial permeability transition pore (mPTP). This prevents leakage of ROS and intermembrane space (IMS) proteins due to mitochondrial outer membrane permeabilization during the opening of mPTP.(B) To determine the state of the mPTP in hiPSC-ECs, the cobalt/calcein AM (green) quenching method was used. hiPSC-EC NCRM1 treated with CsA for 30 min prevented calcein leakage, indicating that CsA closed the mPTP.(C) TEM image shows the ultrastructure of mitochondria of hiPSC-ECs treated with 500 nM CsA during differentiation.(D) Representative cross-sectional confocal images stained for MitoTracker red (oxidative mitochondria) and MitoTracker green (mitochondria) of hiPSC-ECs NCRM1 treated with CsA. (E) Quantification of percentage of mature mitochondria on TEM stitches (21 cells/group). (F and G) Quantitative analysis of mitochondrial morphology by analyzing MitoTracker confocal images. Individual particles (mitochondria) were analyzed for circularity and lengths of major and minor axes. From these values, aspect ratio (AR; major/minor) (F) and form factor (FF; perimeter^2^/4π × area) (G) were calculated. Both FF and AR have a minimal value of 1 when a particle is a small perfect circle, and the values increase as the shape becomes elongated. AR is a measure of mitochondrial length, and an increase of FF represents increase in length and branching (10 cells/group).(H) Quantitative analysis of the area stained by MitoTracker red (oxidative mitochondria) divided by the area stained for MitoTracker green (mitochondria) (10 cells/group).Values are presented as mean ± SEM of n = 3--5 independent experiments. One-way ANOVA was performed; ^∗^p \< 0.05, ^∗∗^p \< 0.001, ^∗∗∗^p \< 0.0001.

Treatment of hiPSC-ECs with CsA for a week during differentiation starting on day 5 revealed high numbers of mature, elongated cristae-rich mitochondria similar to those observed in hMVECs on TEM ([Figures 4](#fig4){ref-type="fig"}C and 4E). The same morphology was observed with confocal microscopy using MitoTracker dyes ([Figures 4](#fig4){ref-type="fig"}D and [S5](#mmc1){ref-type="supplementary-material"}A). Analysis of the mitochondrial morphology further supported the maturation of the mitochondria, with a higher aspect ratio and form factor in hiPSC-ECs treated with CsA, indicating increased elongation and reduced circularity of the mitochondria ([Figures 4](#fig4){ref-type="fig"}F and 4G). A trend toward more oxidative mitochondria was also observed ([Figure 4](#fig4){ref-type="fig"}H).

Improved Mitochondrial Function after Treatment with CsA {#sec2.7}
--------------------------------------------------------

CsA treatment during the differentiation of hiPSC-ECs restored mitochondrial function by increasing maximal mitochondrial respiration and reserve capacity and increasing mitochondrial activity as detected by the MTT to levels similar to those in hMVECs ([Figures 5](#fig5){ref-type="fig"}A--5D). Concomitantly, CsA led to significantly reduced levels of ROS ([Figure 4](#fig4){ref-type="fig"}E). This reduction was also observed after treating the cells with MitoTEMPO ([Figure 5](#fig5){ref-type="fig"}E), a mitochondria-specific antioxidant, which further suggested that ROS is produced by the dysfunctional mitochondria ([Figure 5](#fig5){ref-type="fig"}E). However, treatment with MitoTEMPO during differentiation did not lead to mitochondrial maturation ([Figure 5](#fig5){ref-type="fig"}D). The reduction in ROS after treatment with CsA is not due to changes in mitochondrial content, since the amount of mitochondria is not significantly different ([Figures 5](#fig5){ref-type="fig"}F and 5G) Together, these findings indicated that maturation of mitochondria could be induced by closure of the mPTP with CsA.Figure 5Treatment with Cyclosporine A Results in Improved Mitochondrial Function in hiPSC-ECs(A--C) The OCR revealed increased mitochondrial function in hiPSC-EC NCRM1 treated with 500nM CsA during differentiation (A).Both maximal mitochondrial respiration (B) and mitochondrial reserve capacity (C) were increased in hiPSC-ECs treated with CsA (n = 3).(D) Mitochondrial activity was also tested by MTT after addition of 500 nM CsA or 10 mM MitoTEMPO during differentiation. CsA results in an increased mitochondrial activity, whereas MitoTEMPO did not increase mitochondrial activity.(E) Fold change of fluorescent intensity per mg of protein of ROS staining shows reduced ROS of CsA-treated cells. The same effect was obtained by addition of 10 mM MitoTEMPO.(F and G) Mitochondrial DNA measured with qPCR (F) and mitochondrial density quantified on TEM stitches (21 cells/group) (G) after treatment of CsA during differentiation.Values are presented as mean ± SEM of n = 3--4 independent experiments. One-way ANOVA or non-paired two-tailed Student\'s t test was performed; ^∗^p \< 0.05, ^∗∗^p \< 0.001, ^∗∗∗^p \< 0.0001; ns, not significant.

Closure of mPTP Restores Glycocalyx Formation and Improves Functionality of hiPSC-ECs {#sec2.8}
-------------------------------------------------------------------------------------

After treating the hiPSC-ECs with CsA during differentiation, we exposed them to 4 days of laminar flow to assess the glycocalyx and morphological responses. The mPTP was still closed after 4 days of flow, assessed by the cobalt/calcein method as described earlier, even without addition of CsA during the flow ([Figure S5](#mmc1){ref-type="supplementary-material"}C). CsA significantly increased luminal thickness of hyaluronan, lectin, and heparan sulfates compared with untreated hiPSC-ECs ([Figures 6](#fig6){ref-type="fig"}A, 6B, and [S6](#mmc1){ref-type="supplementary-material"}A). Given the role of glycocalyx as a shear stress mechanotransducer, we hypothesized that normalization of the glycocalyx might lead to restoration of alignment to shear. Indeed, treatment of hiPSC-ECs with CsA resulted in improved alignment to the shear stress ([Figures 6](#fig6){ref-type="fig"}C, 6D, and [S6](#mmc1){ref-type="supplementary-material"}B).Figure 6Treatment with Cyclosporine A Restores the Glycocalyx and Improves Alignment to Flow(A) Representative side-view confocal images stained for hyaluronan (Neurocan, red), lectin (LEA, green), and heparan sulfate (JM403, green) after 4 days of laminar flow culture of hMVECs, hiPSC-ECs control, and hiPSC-EC NCRM1 treated with 500 nM CsA during differentiation.(B) Quantification of luminal thickness of hyaluronan, lectin *Lycopersicon esculentum*, and heparan sulfates after 4 days of laminar flow of hMVECs, hiPSC-ECs, and hiPSC-ECs treated with CsA (8--16 cells/group).(C) Representative cross-sectional confocal images of VE-cadherin (green) and Hoechst (blue) show the alignment of cells to flow.(D) Quantification of cell alignment after 4 days of laminar flow culture of hMVECs, hiPSC-ECs, and hiPSC-ECs treated with CsA (100 cells/group).Values are presented as mean ± SEM of n = 3 independent experiments. One-way ANOVA was performed; ^∗^p \< 0.05, ^∗∗^p \< 0.001, ^∗∗∗^p \< 0.0001.

Discussion {#sec3}
==========

ECs exposed to laminar shear stress express a thick glycocalyx on their surface that plays an important role in reducing vascular permeability and endothelial anti-inflammatory, antithrombotic, and antiangiogenic properties. Our results show that prolonged exposure to shear stress initially failed to induce endothelial quiescence or maturation in hiPSC-ECs. We showed that hiPSC-ECs essentially lack a functional glycocalyx and do not align to the shear stress as primary ECs. Several studies have also demonstrated a role for pericytes in inducing EC quiescence and vessel stability ([@bib37], [@bib60]). Our data, however, showed that additional co-culture of hiPSC-ECs with pericytes under shear also failed to induce endothelial quiescence and the synthesis of a glycocalyx layer. Nonetheless, we recently demonstrated that pericyte-EC signaling actually requires an intact glycocalyx layer, implicating the dysfunctional glycocalyx as the potential cause for failure of hiPSC-ECs and pericyte interaction ([@bib66]).

It has been well documented that in general, when hiPSCs commit to differentiation, they undergo metabolic remodeling so that they become less reliant on glycolysis and more dependent upon mitochondrial respiration ([@bib27], [@bib72], [@bib79]). This has also been described for mesodermal differentiation ([@bib14]), even though ECs preserve relatively high glycolysis ([@bib10], [@bib22], [@bib71]). One hypothesis is that failure to establish an accurate metabolic switch may have negatively affected the maturation and functionality of iPSC-ECs. It was therefore noteworthy that glycolysis was not different between hiPSC-ECs and hMVECs.

The Seahorse data did show, however, reduced mitochondrial capacity for oxidative phosphorylation, despite higher overall mitochondrial content in the hiPSC-ECs. Furthermore, ultrastructural analysis showed immature, round mitochondria that lacked mature cristae development and were associated with increased ROS leakage. Together, these data indicated an open mPTP, which is characteristic of mitochondrial immaturity. Previous studies have shown the importance of mitochondria and mPTP activity in differentiation and stem cell fate ([@bib11], [@bib32], [@bib33], [@bib68], [@bib73]). Chemical closure of the mPTP has been shown to increase mitochondrial maturation, regulate redox signaling, and enhance differentiation of cardiomyocytes by 10- to 20-fold ([@bib32], [@bib73]). Our data showed that prolonged closure of mPTP with CsA in hiPSC-ECs resulted in more functional mature mitochondria and prevention of ROS leakage. Furthermore, we found that maturation of the mitochondria led to functional improvements that included restoration of the glycocalyx and subsequent restoration of the mechanotransduction in hiPSC-ECs. Moreover, reduction of ROS may also be directly involved in restoration of glycocalyx, since ROS can lead to direct heparan sulfate and hyaluronan fragmentation by oxidative reductive depolymerization ([@bib41], [@bib55], [@bib63]).

As ECs generate ATP mostly through glycolysis, the mitochondria act as signaling organelles via generation of ROS in addition to producing the metabolic intermediates necessary for cell growth. This activates transcriptional networks and, via metabolic intermediates, controls epigenetic regulation ([@bib2], [@bib16], [@bib35], [@bib58]). The impact of mitochondrial maturation on these regulatory functions requires further study. The elongated mature mitochondria of hiPSC-ECs treated with CsA illustrate the importance of efficient biosynthetic organelles to support sufficiently the proliferation required for angiogenesis ([@bib8], [@bib19]). This angiogenic capacity together with a functional glycocalyx, necessary for growth factor signaling and anticoagulation, is a prerequisite for future hiPSC-EC applications in tissue engineering ([@bib38]) and organoid vascularization ([@bib65]), and in future therapeutic applications of hiPSC-ECs, such as wound healing ([@bib13]). This study demonstrated that mitochondrial maturation can be pharmacologically regulated in hiPSC-derived cells to generate more mature and representative differentiation products.

Experimental Procedures {#sec4}
=======================

hiPSC Culture and EC Differentiation {#sec4.1}
------------------------------------

NCRM1 was obtained from RUCDR (reprogramming of CD34^+^ cord blood using episomal vectors). LUMC0072iCTRL01 (L72) and LUMC0099iCTRL04 (L99) were generated by the LUMC iPSC core facility from fibroblasts on mouse embryonic fibroblasts using a Simplicon RNA Reprogramming Kit (Millipore-Merck, Amsterdam, the Netherlands) and ReproRNA (STEMCELL Technologies) respectively, as described previously ([@bib75]) and further cultured in TeSR-E8 medium (STEMCELL). The hiPSC-ECs were generated from these lines according to [@bib46]. In short, hiPSCs maintained on Matrigel-coated (Corning) plates in TeSR-E8 medium were routinely enzymatically passaged weekly. Differentiation was induced 4 days after passaging (day 0). Mesoderm specification was induced by adding bone morphogenetic protein 4 (R&D Systems), activin A (Miltenyi Biotec), small-molecule inhibitor of glycogen synthase kinase 3β (Tocris Bioscience), and vascular endothelial growth factor (VEGF; Miltenyi Biotec). Mesoderm-inducing factors were removed on day 3 of differentiation and replaced by vascular specification medium containing VEGF and the transforming growth factor β (TGF-β) pathway small-molecule inhibitor SB431542 (Tocris Bioscience). SB431542 allows expansion of ECs by inhibiting the antiproliferative activities of TGF-β also present in the culture. Vascular specification medium was refreshed on days 7 and 9 of differentiation and hiPSC-ECs were isolated on day 10 using anti-CD31 antibody-coupled magnetic beads (Dynabeads; Miltenyi Biotech). hiPSC-ECs were then transferred to EC serum-free medium (EC-SFM; Gibco, Thermo Fisher Scientific) to which platelet-poor plasma (1% v/v) (Biomedical Technologies), 50 μg/mL VEGF-165 (R&D Systems), and 100 μg/mL basic fibroblast growth factor (Miltenyi Biotech) had been added (EC-SFM full medium) at 37°C with 5% CO~2~ and antibiotics (100 IU/mL penicillin and 100 μg/mL streptomycin; Life Technologies Gibco).

Primary Human Microvascular EC Culture {#sec4.2}
--------------------------------------

hMVECs were isolated from human kidney cortical tissue and were purchased from Cell Systems (ACBRI-128, Kirkland, WA). They were available at passage 3 (\<12 cumulative population doublings) cryopreserved in CSC Cell Freezing Medium (4Z0-705). hMVECs were also cultured in EC-SFM full medium at 37°C with 5% CO~2~ and antibiotics (100 IU/mL penicillin and 100 μg/mL streptomycin).

Flow Experiments {#sec4.3}
----------------

Shear experiments were performed using an Ibidi flow system (Ibidi). Cells were cultured for 4 days at a constant laminar shear stress of 5 dyne/cm^2^, at moderated physiological flow ([@bib9], [@bib28]) in EC-SFM full medium as previously described ([@bib4], [@bib66]). Cells were seeded into closed perfusion chambers (ibiTreat 0.4 μ-Slide I or VI; Luer) at a concentration of 1.4 × 10^6^ cells/mL and allowed to adhere for 3 h. Thereafter, the chamber was connected to a computer-controlled air-pressure pump and a fluidic unit with a two-way switching valve. The pump setup allowed pumping of 16 mL of cell-culture medium from two reservoirs in a unidirectional way through the flow channel over the monolayer of ECs at a constant shear stress of 5 dyne/cm^2^. Medium was refreshed after 1 day of culture. The chamber and the reservoirs containing the medium were kept in an incubator at 37°C and 5% CO~2~. RNA was isolated from cells subjected to shear stress in a 0.4 μ-Slide I Luer flow chamber, while the six lanes of a 0.4 μ-Slide VI Luer were used for immunofluorescent staining.

MitoTracker Staining and Quantification {#sec4.4}
---------------------------------------

MitoTracker probes (Invitrogen) were used to visualize mitochondria. Live cells were loaded with MitoTracker Green FM, MitoTracker Red CM-H2XRos (100 nM, Thermo Fisher, M7513) and Hoechst 33258 (Life Technologies, H3569) for 30 min at 37°C and imaged using a Leica SP8 white-light laser confocal immunofluorescence microscope. Analysis of mitochondrial morphology was quantified as described previously ([@bib36], [@bib76]). After filtering for median of two pixels, making the picture binary and thresholding, the individual particles were analyzed for circularity (4π × area/perimeter^2^) and length of the minor and minor axes.

The ratio between MitoTracker red and green was also quantified by thresholding and selection of single cells, followed by measuring the stained area of MitoTracker red and MitoTracker green. For each independent experiment (n = 5), 10 cells per group were analyzed with up to 250 particles per cell.

Fluorescent Quantification {#sec4.5}
--------------------------

Surface hyaluronan expression (Ncan-dsRed), lectin binding (LEA; 10 μg/mL, Sigma-Aldrich, L2895) and heparan sulfate (JM403; 1.1 mg/mL, gift from Dr. van der Vlag and Dr. Kuppevelt \[Nijmegen Center for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands\]) were quantified on 4 cells per field of view essentially as described earlier ([@bib4], [@bib66]). From a side view, resliced from a line (10 pixels wide) over the nucleus, three additional lines were drawn at the nuclear position and the mean fluorescence was calculated between the distance from half-maximum signal of the nuclear staining to half-maximum signal at the luminal end. Eight to 20 cells per group were analyzed from each independent experiment (n = 4). The difference between stable adherence junctions and focal adherence junctions (FAJ) upon junction remodeling ([@bib34]) was quantified as the ratio of FAJ length over total junction length ([@bib62]). One hundred cells were analyzed from each independent experiment (n = 4).

Metabolic Assays {#sec4.6}
----------------

To measure endothelial glycolytic flux, we seeded hMVECs and hiPSC-ECs overnight at 4 × 10^4^ cells per well on fibronectin-coated (Sigma-Aldrich) Seahorse XF96 polystyrene tissue culture plates (Seahorse Bioscience). The plate was incubated in unbuffered DMEM assay medium (Sigma-Aldrich) for 1 h in a non-CO~2~ incubator at 37°C before measuring in an XFe 96 extracellular flux analyzer (Seahorse Bioscience). OCR (data not shown) and ECAR were measured over 4-min periods with 2-min mixing in each cycle, with five cycles in total. Inhibitors and activators were used at the following concentrations: glucose (10 mM), oligomycin (3 μM), 2-deoxyglucose (100 mM), carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP; 1 μM), antimycin A (1.5 μM), and rotenone (3 μM) (all Sigma-Aldrich). Cellular protein content was determined with a BCA-protein kit from Pierce (Thermo Fischer Scientific), and the data are presented as ECAR normalized to protein. Each measurement was averaged from triplicate wells. To calculate these parameters, we considered basal OCR as the last value prior to injection of the first additive (oligomycin). Likewise, we considered OCR on oligomycin as the last value prior to FCCP injection, OCR on FCCP as the last value prior to antimycin plus rotenone injection, and non-mitochondrial OCR as the last value recorded after antimycin plus rotenone.

As described previously ([@bib20], [@bib25]), we then calculated the following parameters. Basal respiration was determined as OCR in the basal state minus non-mitochondrial OCR. Maximal respiration was calculated as OCR on FCCP minus non-mitochondrial OCR. The reserve capacity was calculated as maximal respiration minus basal respiration.

To measure intracellular reactive oxygen species, we used the Cellular ROS/Superoxide detection assay kit (Abcam, ab139476). ECs plated in a black 96-well plate (20,000 cells per well) were incubated with ROS/Superoxide detection mix (2 μM) for 30 min at 37°C in darkness. As positive and negative controls, the ROS inducer pyocyanin (200 μM) and ROS inhibitor *N*-acetyl-L-cysteine (5 mM) were used 1 h or 30 min in advance, respectively. Cells were then washed twice with washing buffer and immediately observed for fluorescein and rhodamine in a Molecular Devices Spectramax i3x. Cellular protein content was determined with a BCA-protein kit from Pierce (Thermo Fisher Scientific), and the data are presented as ROS normalized to protein. Each measurement was averaged from quadruplicate wells.

CsA (Sigma, \#30024) was added at a concentration of 500 nM to the vascular medium during differentiation, starting on day 5 of vascular medium, and continued for 1 week.

Statistical Analysis {#sec4.7}
--------------------

Results are presented as mean ± SD or mean ± SEM, where n is the number of biological independent experimental replicates. Differences between groups were assessed by non-paired two-tailed Student\'s t test, paired two-tailed Student\'s t test, or, when not normally distributed, by two-tailed F test. Differences between more than two groups were assessed by ANOVA. p values of \<0.05 were considered statistically significant.
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